glucuronic acid has been researched along with Cranial Nerve II Injuries in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asai, N; Furukawa-Hibi, Y; Miyamoto, Y; Mori, H; Nakatani, M; Nishimura, S; Nitta, A; Shinohara, Y; Takii, M | 1 |
1 other study(ies) available for glucuronic acid and Cranial Nerve II Injuries
| Article | Year |
|---|---|
Periocular injection of in situ hydrogels containing Leu-Ile, an inducer for neurotrophic factors, promotes retinal ganglion cell survival after optic nerve injury.
Topics: Alginates; Animals; Blotting, Western; Brain-Derived Neurotrophic Factor; Cell Survival; Cyclic AMP Response Element-Binding Protein; Delayed-Action Preparations; Dipeptides; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Carriers; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Glial Cell Line-Derived Neurotrophic Factor; Glucuronic Acid; Hexuronic Acids; Hydrogels; Immunoenzyme Techniques; Injections, Intraocular; Male; Nerve Growth Factors; Neuroprotective Agents; Optic Nerve Injuries; Poloxamer; Rats; Rats, Wistar; Retinal Ganglion Cells; Signal Transduction; Spectrometry, Fluorescence; Time Factors; Up-Regulation | 2011 |